ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

WOK vs INBS // GROSS PROFIT MARGIN

WORK Medical Technology Group LTD (Class A) (NASDAQ) VS. Intelligent Bio Solutions Inc. (NASDAQ) • 15-METRIC TALLY: WOK 1 — INBS 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (WOK VS. INBS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC WOK INBS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — 40.80% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — -35.00% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — -1.90% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 3/9 +1.00 WOK /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 34.8 56.9 -22.10 INBS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $4.9M $6.1M -$1.2M INBS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR WOK REV INBS REV WOK GROSS % INBS GROSS % WOK FCF INBS FCF
FY 2025 $0 $3.1M — 40.8% $4.9M -$9.9M
FY 2024 $0 $3.1M — 45.8% -$11.5M -$9.8M
FY 2023 $0 $1.3M — — $2.2M -$7.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
WOK // BETA —
INBS // BETA —